| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8657293 | Atherosclerosis Supplements | 2017 | 13 Pages |
Abstract
This study demonstrates that patients with Lp(a) elevation benefit most from LA treatment. Prospective trials to confirm these data are warranted.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
U. Schatz, S. Tselmin, G. Müller, U. Julius, B. Hohenstein, S. Fischer, S.R. Bornstein,